Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.57
+0.39 (4.25%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 371 employees as of December 31, 2025. The number of employees decreased by 56 or -13.11% compared to the previous year.
Employees
371
Change (1Y)
-56
Growth (1Y)
-13.11%
Revenue / Employee
$645,989
Profits / Employee
-$267,040
Market Cap
760.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | -56 | -13.11% |
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| MapLight Therapeutics | 133 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 88 |
| Crescent Biopharma | 69 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Shattuck Labs | 40 |
PHAT News
- 15 days ago - Phathom Pharmaceuticals price target lowered to $14 from $18 at Barclays - TheFly
- 4 weeks ago - Phathom Pharmaceuticals price target lowered to $20 from $22 at Craig-Hallum - TheFly
- 4 weeks ago - Phathom Pharmaceuticals price target lowered to $21 from $28 at Raymond James - TheFly
- 4 weeks ago - Phathom Pharmaceuticals price target lowered to $22 from $25 at Guggenheim - TheFly
- 4 weeks ago - Phathom Pharmaceuticals price target lowered to $22 from $28 at Needham - TheFly
- 4 weeks ago - Phathom Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Phathom Pharmaceuticals Earnings release: Q2 2026 - Filings
- 4 weeks ago - Phathom Pharmaceuticals Quarterly report: Q2 2026 - Filings